Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Stephan Kiefer outlines the iManageCancer platform

Stephan Kiefer – Fraunhofer Institute for Biomedical Engineering IBMT, Sulzbach, Germany
Stephan Kiefer outlines the iManageCancer platform ( Stephan Kiefer – Fraunhofer Institute for Biomedical Engineering IBMT, Sulzbach, Germany )
6 Aug 2018

iManageCancer clinical pilot design and preliminary outcomes

Dr Chiara Renzi - European Institute of Oncology, Milan, Italy
iManageCancer clinical pilot design and preliminary outcomes ( Dr Chiara Renzi - European Institute of Oncology, Milan, Italy )
6 Aug 2018

A pilot study for the iManageCancer platform

Dr Chiara Renzi - European Institute of Oncology, Milan, Italy
A pilot study for the iManageCancer platform ( Dr Chiara Renzi - European Institute of Oncology, Milan, Italy )
6 Aug 2018

The 'My Health Avatar' app for iManageCancer

Prof Feng Dong - University of Bedfordshire, Luton, UK
The 'My Health Avatar' app for iManageCancer ( Prof Feng Dong - University of Bedfordshire, Luton, UK )
6 Aug 2018

Patient empowerment through iManageCancer

Prof Gordon McVie - ecancer, Bristol, UK
Patient empowerment through iManageCancer ( Prof Gordon McVie - ecancer, Bristol, UK )
6 Aug 2018

21st century medicine is transforming healthcare and the diagnosis and treatment of cancer

Dr Leroy Hood - Institute For Systems Biology, Seattle, USA
21st century medicine is transforming healthcare and the diagnosis and treatment of cancer ( Dr Leroy Hood - Institute For Systems Biology, Seattle, USA )
9 Jul 2018

The TAPUR trial family: a global data sharing platform

Dr Richard Schilsky - American Society Of Clinical Oncology, USA
The TAPUR trial family: a global data sharing platform ( Dr Richard Schilsky - American Society Of Clinical Oncology, USA )
9 Jul 2018

Biobanking and early diagnosis to defeat NSCLC

Dr Amir Onn - Chaim Sheba Medical Center, Ramat Gan, Israel
Biobanking and early diagnosis to defeat NSCLC ( Dr Amir Onn - Chaim Sheba Medical Center, Ramat Gan, Israel )
6 Jul 2018

Patients access to precision oncology

Prof Francesco de Lorenzo - European Cancer Patient Coalition (ECPC), Brussels, Belgium
Patients access to precision oncology ( Prof Francesco de Lorenzo - European Cancer Patient Coalition (ECPC), Brussels, Belgium )
6 Jul 2018

Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives?

Dr Giorgio Massimini - Merck KGaA, Germany
Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives? ( Dr Giorgio Massimini - Merck KGaA, Germany )
6 Jul 2018

U.S. National Cancer Institute perspective on precision oncology

Dr James Doroshow - National Cancer Institute, NIH, Bethesda, USA
U.S. National Cancer Institute perspective on precision oncology ( Dr James Doroshow - National Cancer Institute, NIH, Bethesda, USA )
6 Jul 2018

WINTHER & SPRING: Targeted agents and triple agent combinations

Dr Razelle Kurzrock - UC San Diego Moores Cancer Center, San Diego, USA
WINTHER & SPRING: Targeted agents and triple agent combinations ( Dr Razelle Kurzrock - UC San Diego Moores Cancer Center, San Diego, USA )
6 Jul 2018